| Jerene Leferink, SLP | |
|
1460 Curve Crest Blvd W, Stillwater, MN 55082-6070 | |
| (651) 439-8283 | |
| (651) 439-0576 |
| Full Name | Jerene Leferink |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1460 Curve Crest Blvd W, Stillwater, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073719902 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 5703 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jerene Leferink, SLP 1460 Curve Crest Blvd W, Stillwater, MN 55082-6070 Ph: (651) 439-8283 | Jerene Leferink, SLP 1460 Curve Crest Blvd W, Stillwater, MN 55082-6070 Ph: (651) 439-8283 |
News Archive
Accurate determination of viral titers is critical to vaccine development. Historically, titers have been determined using endpoint assays which are labor-intensive, expensive, and time-consuming. This is increasingly problematic in modern production facilities where bioprocess optimization is performed using high-throughput cell culture reactors that can produce batches of virus faster than they can be analyzed.
A new Tel Aviv University study suggests that a therapy that combines Virtual Reality and treadmill exercise dramatically lowers the incidence of falling among Parkinson's patients by changing the brain's behavior and promoting beneficial brain plasticity, even in patients with neurodegenerative disease.
For Angela Wandinger-Ness, PhD, giving back to society and investing in the future are the same thing. "That was the hook," she says. "If you're going to be in academics, you're there to do research and teaching and education."
Northwest Biotherapeutics (NASDAQ: NWBO)(NW Bio), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that it has received a decision from the German regulatory agency (the Paul Ehrlich Institute, or PEI) under which the Company's Phase III clinical trial will be able to proceed in Germany after the Company makes three modifications, none of which affect the body of the trial or the bases for seeking product approval.
› Verified 5 days ago
Ms. Lori Jean Griffith Olson, MS/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1421 Trotter Ct, Stillwater, MN 55082 Phone: 651-430-2482 | |
Mrs. Rachel Marshall, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1119 Owens St N, Stillwater, MN 55082 Phone: 651-439-7180 | |
Mara Logerquist, M.S., CF-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1500 Curve Crest Blvd W, Stillwater, MN 55082 Phone: 651-439-1234 Fax: 651-275-3325 | |
Kelly J Lessman, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1460 Curve Crest Blvd W, Stillwater, MN 55082 Phone: 651-439-8283 Fax: 651-439-0576 | |
Michele M Dorenkamp, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1460 Curve Crest Blvd W, Stillwater, MN 55082 Phone: 651-439-8283 Fax: 651-439-0576 | |
Erika Olson, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1460 Curve Crest Blvd W, Stillwater, MN 55082 Phone: 651-439-8283 Fax: 651-439-0576 |